Novartis Heart Drug Pelacarsen Fails Phase 3 Clinical Trial
Novartis and Ionis Pharmaceuticals announced on September 4, 2026, that their experimental heart drug pelacarsen failed a pivotal Phase 3 clinical trial.
Geoff Meacham
Just In
- 2 minutes agoLiving with Malaria: A Childhood Without End
- 6 minutes agoCERNQ52: Is an Earth-Impacting Asteroid Imminent?
- 8 minutes ago18-Year-Old Dies in Davos Car Crash Hospitalized
- 14 minutes agoAmazon Cargo Plane Runway Excursion Halts Miami Airport Traffic
- 19 minutes agoTrump Proposes Changing New Mexico’s State Name
- 26 minutes agoRichard Tesařík, Co-Founder and Frontman of Yo Yo Band, Dies at 80
- 28 minutes agoHüseyin Çimşir: I Don’t Sell False Hopes
- 31 minutes agoThis Robot Vacuum Can Now Climb Stairs
Latest
- Living with Malaria: A Childhood Without End2 minutes ago
- CERNQ52: Is an Earth-Impacting Asteroid Imminent?6 minutes ago
- 18-Year-Old Dies in Davos Car Crash Hospitalized8 minutes ago
- Amazon Cargo Plane Runway Excursion Halts Miami Airport Traffic14 minutes ago
- Trump Proposes Changing New Mexico’s State Name19 minutes ago
- Richard Tesařík, Co-Founder and Frontman of Yo Yo Band, Dies at 8026 minutes ago
Popular
- Japanese Probe Performs Close Flyby of Asteroid Torifune with Czech Contribution2 months ago
- Jessica ‘Reflections’ Concert Tour 2026 in Bangkok: PPTVHD36 Guide2 months ago
- 2026 World Cup Winner Predictions: Quarter-Finalists Analysis2 months ago
- Samsung Unpacked July 22: What to Expect from Next-Gen Foldables2 months ago
- Everything You Need to Know About the New Mandatory Card2 months ago
- Westpac Urges Staff to Use AI Sensibly Amid Rising Costs2 months ago